Patent ID: 8865687
Filing Date: 2014-10-21
Classification: A23L,A23V,A61K,A61P

Abstract:
1. A method for treating a person suffering from or being at risk of degeneration of cerebral function, cognitive degeneration and/or dementia syndromes associated with vascular disorders; vascular degeneration of cerebral function, vascular cognitive degeneration, vascular dementia and/or Alzheimer's disease, the method comprising administering to a person in need thereof a preparation, comprising: a) at least 120 mg per daily dosage of a long chain polyunsaturated fatty acid (LCPUFA) fraction comprising docosahexaenoic acid (DHA); b) at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine; and c) folic acid and vitamin B6, wherein the amount of folic acid is at least 200 μg per daily dosage.